Cloudflare CEO Matthew Prince sold $15.1 million in company stock during the first week of August 2026, according to SEC Form 4 filings, continuing a pattern of scheduled sales that has run since February.
What did Cloudflare's insider filings show?
SEC Form 4 filings from Cloudflare CEO Matthew Prince showed roughly $15.1 million in stock sales across August 4 and 5, 2026, executed under a pre-set trading plan rather than a discretionary decision. The sales came through a family trust and continue a pattern in place since February.
Filings show Prince sold 51,034 Class A shares between $287.99 and $303.60 through the Prince 2021 Remainder Trust. A $9.96 million tranche on August 5 alone accounted for 33,631 of those shares, sold between $291.07 and $303.19. Both tranches trace back to a Rule 10b5-1 plan Prince adopted on February 26, 2026, not a fresh decision to sell. He also converted 52,383 Class B shares into Class A on August 5, standard housekeeping ahead of a plan-driven sale.
Systematic 10b5-1 selling is a lower-signal event than a discretionary open-market sale. The trades were scheduled months in advance, so the timing says little about what Prince thinks of Cloudflare's stock today.
Which member of Congress traded Alphabet stock this month?
Rep. Josh Gottheimer disclosed a purchase of Alphabet stock worth between $8,008 and $120,000, filed in mid-August for a trade that happened in late July. The filing falls within the STOCK Act's standard disclosure window rather than representing a late or unusual report.
Gottheimer's periodic transaction report shows the GOOGL purchase was filed August 10, 2026 for a transaction dated July 24. Members of Congress have up to 45 days after a trade to disclose it under the STOCK Act, so a filing roughly two and a half weeks later is ordinary, not a compliance flag.
How far did Moderna actually rally, and has it held?
Moderna spiked as much as 177% intraday on August 19 after positive late-stage trial data for a personalized cancer vaccine, one of the sharpest single-day biotech moves this year. Part of that gain has already reversed: the stock closed August 21 well below its intraday peak.
The rally followed trial results for an mRNA melanoma vaccine, which sent shares as high as roughly $174.93 in the two sessions after the data. By the close on August 21, MRNA was trading at $145.13, up 8.86% on the day but down sharply from the peak. A single-day spike followed by a multi-day giveback is a different trade than a clean, sustained weekly gain.
Where did the S&P 500 actually close this week?
The S&P 500 closed at 7,674.37 on August 21, up 0.43% on the day, recovering after a rougher week driven by rising Treasury yields. The index remains within range of record territory but had not printed a fresh all-time high as of that close.
That close, confirmed across CNBC and Yahoo Finance market data, came after a stretch of yield-driven volatility earlier in the week. A level near 7,674 is roughly 2,000 points above where the index traded through most of 2024, a gap worth flagging given how easily an old price level gets mistaken for a current one in a fast-moving market.
What did July's CPI report show?
Headline CPI rose 0.1% in July and sits 3.4% above where it was a year earlier. Core CPI, which excludes food and energy, rose 0.2% for the month and 2.5% year over year. Both readings came in a tenth of a point cooler than June's.
The July print, confirmed by the Bureau of Labor Statistics, showed no fresh acceleration in inflation even as prices remain well above the Fed's 2% target. Cooler core inflation next to a softening labor market, below, is the combination the Fed will weigh heading into its September meeting.
Did the Fed raise rates in July?
No. The FOMC held its target range at 3.50%-3.75% on July 29, the fifth consecutive meeting without a move. The vote was not unanimous: three regional Fed presidents dissented in favor of a hike.
The Federal Reserve's July 29 statement confirmed the hold, but Cleveland's Beth Hammack, Minneapolis's Neel Kashkari, and Dallas's Lorie Logan all dissented in favor of raising rates, an unusually large hawkish dissent bloc for a decision to stand pat.
What did the July jobs report show?
Nonfarm payrolls fell by 23,000 in July, missing a Dow Jones consensus forecast for a gain of 83,000. Unemployment ticked down to 4.1%, but that reflected fewer people working or looking for work, not stronger hiring.
The Bureau of Labor Statistics report also showed wage growth slowing to 3.2% year over year, the softest pace since May 2021, and cut May and June's combined job gains by 103,000. A weak labor print sitting next to a Fed that just held rates against three hawkish dissents is the tension worth watching into the September 15-16 meeting.
Track live insider trades, congressional filings, and macro data at opticalpha.net/terminal. 14-day free trial, no credit card required.